文献速递中毒与环境急症重症综合管理与镇静镇痛心脑血管急症

老年中毒患者迅速增加且病情较年轻患者更重

Poisoning in the elderly is increasing rapidly and is more severe than younger patients.
PubMed 文献 · Clin Toxicol (Phila) · 2026-03-18
一句话结论老年(≥65岁)中毒住院人数35年间从111例增至449例,心脏并发症与急性肾损伤多于非老年,但ICU入住率与死亡率在近五个五年段分别降至13%和1.3%。

该研究基于一家三级毒理学服务中心1990—2024年前瞻性临床数据库,比较老年(≥65岁)与非老年(19—64岁)中毒住院患者。老年中毒住院从1990—1994年的111例增至2020—2024年的449例(占全部中毒住院比例由5.1%升至9.8%)。老年患者更多摄入心脏药物、更少摄入精神药物,中位住院时间、ICU入住率和死亡率均高于非老年。近十年老年患者心律失常(4.2% vs 1.3%)、低血压(8.0% vs 3.4%)和急性肾损伤(4.2% vs 1.3%)更多,神经系统并发症(昏迷与谵妄)相似;65至≥85岁并发症随年龄增加,但≥85岁患者接受关键监护干预减少。

要点

  • 老年中毒住院从1990—1994年111例增至2020—2024年449例,占全部中毒住院比例由5.1%升至9.8%。
  • 老年患者较非老年更多摄入心脏药物、更少摄入精神药物,中位住院时间、ICU入住率与死亡率均更高。
  • 近十年(2015—2024)老年患者心律失常4.2% vs 1.3%、低血压8.0% vs 3.4%、急性肾损伤4.2% vs 1.3%,均多于非老年。
  • 老年患者昏迷与谵妄等神经系统并发症与非老年相似。
  • 并发症随年龄从65岁至≥85岁增加,但≥85岁患者接受正性肌力药与透析等关键监护干预减少。

适用人群与场景

  • 老年组为≥65岁中毒住院患者,非老年组为19—64岁中毒住院患者,均来自一家三级毒理学服务中心1990—2024年的中毒住院病例。

研究设计与关键结果

  • 研究类型为基于一家三级毒理学服务中心前瞻性临床数据库的中毒住院队列分析,1990—2024年共纳入老年中毒住院1,532例、非老年中毒住院24,912例。
  • 老年中毒住院从1990—1994年111例增至2020—2024年449例,占全部中毒住院比例由5.1%升至9.8%。
  • 老年患者较非老年更多摄入心脏药物、更少摄入精神药物;中位住院时间、ICU入住率与死亡率均高于非老年。
  • 1990—1994年至2020—2024年,老年患者中位住院时间由39 h(四分位距18—77 h)降至19 h(四分位距8—39 h),ICU入住由29/111(26%)降至57/449(13%),死亡率由5.4%降至1.3%。
  • 2015—2024年,老年患者心律失常4.2% vs 非老年1.3%、低血压8.0% vs 3.4%、急性肾损伤4.2% vs 1.3%,昏迷与谵妄等神经系统并发症两组相似。
  • 并发症随年龄从65岁至≥85岁增加;老年患者接受正性肌力药与透析更多,但≥85岁患者接受这些干预减少。

证据类型、等级与局限

  • 证据类型为基于单一三级毒理学服务中心前瞻性临床数据库的队列分析。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 老年(≥65岁)中毒患者住院时间更长、ICU入住更多、心脏并发症更多,与年龄增长及所摄入药物相关,临床应对老年中毒患者加强心脏与肾功能监测。
  • 老年中毒患者中,≥85岁者并发症随年龄增加,但接受正性肌力药与透析等关键监护干预减少,床旁决策时需注意这一年龄段的干预差异。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

INTRODUCTION: An aging population has resulted in an increasing burden on health care services. We investigated the epidemiology and severity of poisoning in the elderly (≥65 y) population.

METHODS: Poisoning admissions to a tertiary toxicology service (1990-2024) were extracted. Elderly patients (≥65 y) were compared to non-elderly patients (19-64 y). Data recorded prospectively in a clinical database included demographics, drugs ingested, clinical effects, complications, treatments and outcomes.

RESULTS: There were 1,532 elderly poisoning admissions compared to 24,912 non-elderly admissions. Elderly admissions increased between the first five years (1990-1994) and last five years (2020-2024) from 111 to 449 (5.1-9.8% of all admissions). Elderly patients ingested cardiac medications more often than non-elderly, and fewer psychotropic medications. Median length of stay, intensive care admission, and mortality were higher for elderly patients. All these outcomes improved between the first and last five years: median length of stay decreased from 39 h (interquartile range: 18-77 h) in the first five years to 19 h (interquartile range: 8-39 h) in the last five years; intensive care admission decreased from 29/111 (26%) to 57/449 (13%); and mortality decreased from 5.4% to 1.3%. For the last decade (2015-2024), elderly patients had more cardiac complications (dysrhythmia (4.2% versus 1.3%) and hypotension (8.0% versus 3.4%)) and acute kidney injury (4.2% versus 1.3%), but similar neurological complications (coma and delirium). Morbidity and complications increased with age from 65 to ≥85 y. Elderly patients received more inotropes and dialysis, although less for patients ≥85 y.

DISCUSSION: Elderly patients had longer hospital stays, more intensive care admissions and cardiac complications, consistent with increased age and medications ingested, but this improved over 35 years. Poisoning severity increased with age, but critical care interventions decreased in patients ≥85 years.

CONCLUSIONS: Elderly poisoning cases have rapidly increased, and morbidity and mortality were greater than for non-elderly patients.

来源:Clin Toxicol (Phila),查看原文。版权归原作者所有。

参考来源

  1. Isbister GK, Downes MA, McArdle K, et al. Poisoning in the elderly is increasing rapidly and is more severe than younger patients. Clin Toxicol (Phila). 2026. PMID: 41848290. doi:10.1080/15563650.2026.2631131

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。